123). It can be notable that GLS2 is tumorigenic in breast cancer124, and its expression could compensate for loss of Gls in MYC-induced mouse liver tumours40. This implies that GLS2 could confer resistance to GLS1-distinct inhibitors, such as the allosteric inhibitor BPTES or CB-839, and this resistance could be hypothetically https://ch-22319133210.blogars.com/28454792/everything-about-phenylephrine